Kirin Holdings Company (2503) AI Stock Analysis

• Market Cap: ¥2.23T
• Dividend Yield: 3.05%
• Average Volume (3M): 2.57M
• Price to Earnings (P/E): 14.9
• Beta (1Y): 0.31
• Revenue Growth: 4.75%
• EPS Growth: -24.33%
• Country: JP
• Employees: 31,934
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Beverages - Alcoholic
• EPS (TTM): 55.18
• Shares Outstanding: 914,000,000
• 10 Day Avg. Volume: 2,420,760
• 30 Day Avg. Volume: 2,571,096
• PEG Ratio: 0.08
• Price to Book (P/B): 1.48
• Price to Sales (P/S): 0.78
• P/FCF Ratio: 15.87
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥2,400.00
• Price Target Upside: 0.10% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1
• EPS Forecast (FY): 211.64
• Revenue Forecast (FY): ¥2.46T

• Rating: 71 Outperform
• Price Target: ¥2,963.00 ▲(23.59% Upside)
• Action: Reiterated Date: 02/18/26
• Date: Action: Reiterated 02/18/26

Overall score reflects solid fundamentals (revenue growth and 2025 operating rebound, with supportive but volatile free cash flow) as the main driver, balanced by strong but potentially overextended technical momentum and a reasonable valuation with a moderate dividend yield.

Positive Factors

Steady Revenue Growth

Consistent top-line growth across 2022–2025 indicates durable demand for Kirin's core beverage and health products. A steady revenue base supports longer-term investment planning, capacity utilization, and pricing power, making future margin recovery and reinvestment more feasible.

Operating Profit Rebound (2025)

The pronounced operating profit rebound in 2025 suggests successful cost control or mix improvement that can be sustainable if structural actions persist. Improved operating profitability strengthens cash generation potential and provides a buffer to fund brands, R&D, or deleveraging over multiple quarters.

Diversified Business Model

Kirin's mix of alcoholic, non-alcoholic and pharmaceuticals diversifies revenue drivers and reduces single-market reliance. The pharmaceuticals/health science arm provides exposure to higher-margin or defensive revenue streams, improving resilience against beverage cyclicality over a multi-quarter horizon.

Negative Factors

Rising Leverage

Higher leverage reduces financial flexibility and increases interest and refinancing risk, especially if earnings remain volatile. With debt rising through 2024, Kirin has less headroom to absorb shocks or fund strategic investments without further borrowing or asset disposals over the coming 2–6 months.

Choppy Free Cash Flow

Inconsistent free cash flow makes capital allocation and dividend sustainability harder to predict. Choppiness limits the company's ability to pursue M&A, pay down debt steadily, or increase strategic investments without pressuring liquidity or triggering more leverage in weaker periods.

Volatile Net Income & Weaker ROE

Earnings volatility and declining ROE signal lower efficiency converting equity into profits. This can constrain long-term shareholder returns and indicates potential operational or margin pressures that may persist absent structural fixes, complicating forecasting and capital allocation decisions.

Kirin Holdings Company Business Overview & Revenue Model

Company Description

Kirin Holdings Company, Limited (Ticker: 2503) is a prominent Japanese beverage and food conglomerate, primarily known for its production of alcoholic and non-alcoholic beverages, including beer, soft drinks, and dairy products. Founded in 1907, Kirin operates across several sectors, including its core beer division, which features well-known brands such as Kirin Lager and Ichiban Shibori. The company also engages in the pharmaceutical and biotechnology sectors, producing health-related products. With a strong presence in both domestic and international markets, Kirin focuses on innovation and sustainability in its product offerings.

How the Company Makes Money

Kirin Holdings generates revenue through multiple key streams. The largest revenue source comes from its alcoholic beverage segment, particularly beer sales, which contribute significantly to the company's profits. Additionally, Kirin earns income from non-alcoholic beverages, including soft drinks and mineral water, catering to health-conscious consumers. The dairy segment, which includes products such as milk and yogurt, further diversifies their earnings. Kirin also capitalizes on its pharmaceutical and biotechnology businesses, which add to its revenue through health supplements and treatments. Strategic partnerships and joint ventures, particularly in overseas markets, amplify Kirin's reach and profitability, allowing for increased market share and access to new customer bases. Innovation in product development and a focus on sustainability initiatives also play a crucial role in driving sales and enhancing brand loyalty.

Kirin Holdings Company Financial Statement Overview

Summary

Income statement strength is led by steady revenue growth and a sharp operating profit rebound in 2025, but net income has been volatile. The balance sheet is serviceable yet shows rising leverage through 2024 and weaker ROE. Cash flow is supportive with improved operating cash flow and a strong 2025 free-cash-flow rebound, though free cash flow remains choppy year-to-year.

Income Statement

Revenue has grown steadily from 2022–2025 (annual growth generally positive, with 2025 showing a strong 1.61). Profitability is mixed: gross margin has been stable around the mid-40% range (2022–2024), and operating profit improved sharply in 2025 versus 2024, but net profitability has been volatile (notably weak in 2024 vs 2023 and 2022). Overall, the top-line trajectory and 2025 operating rebound are positives, but earnings consistency is a key weakness.

Balance Sheet

Leverage is moderate but rising: debt-to-equity increased from ~0.53 (2022) to ~0.73 (2024), alongside higher total debt. Equity has also grown over time, providing a cushion, but returns on equity weakened meaningfully in 2024 versus 2022–2023, indicating lower efficiency in converting equity into profits. The balance sheet looks serviceable, but the trend toward higher leverage and softer returns is a watch item.

Cash Flow

Cash generation is solid overall: operating cash flow increased in 2025 versus 2024, and free cash flow improved strongly in 2025 after a softer 2024. However, free cash flow has been choppy year-to-year (declines in 2022 and 2024, rebounds in 2023 and 2025), and in 2024 free cash flow was relatively low compared with net income. Net-net, liquidity looks supportive, but consistency of free cash flow remains a key risk.

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	2.43T	2.34T	2.13T	1.99T	1.82T
Gross Profit	1.16T	1.07T	963.47B	905.71B	822.84B
EBITDA	353.63B	253.42B	294.80B	260.36B	150.70B
Net Income	147.54B	58.21B	112.70B	111.01B	59.79B
Balance Sheet
Total Assets	3.49T	3.35T	2.87T	2.54T	2.47T
Cash, Cash Equivalents and Short-Term Investments	125.29B	127.19B	140.34B	96.44B	157.40B
Total Debt	923.43B	857.57B	733.08B	523.12B	551.47B
Total Liabilities	1.90T	1.82T	1.44T	1.29T	1.32T
Stockholders Equity	1.29T	1.18T	1.13T	980.02B	894.18B
Cash Flow
Free Cash Flow	119.84B	62.26B	89.40B	37.08B	132.97B
Operating Cash Flow	295.43B	242.84B	203.21B	135.56B	219.30B
Investing Cash Flow	-266.79B	-329.38B	-226.09B	-10.40B	-56.41B
Financing Cash Flow	-28.76B	58.13B	35.91B	-167.84B	-180.46B

Kirin Holdings Company Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 2397.50
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2503, the sentiment is Positive. The current price of 2397.5 is below the 20-day moving average (MA) of 2545.00, below the 50-day MA of 2449.77, and above the 200-day MA of 2199.86, indicating a bullish trend. The MACD of 69.39 indicates Negative momentum. The RSI at 68.13 is Neutral, neither overbought nor oversold. The STOCH value of 75.28 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:2503.

Kirin Holdings Company Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
2503	71 Outperform	¥2.23T	14.86	6.93%	3.05%	4.75%	-24.33%
2587	70 Outperform	¥1.50T	17.12	6.97%	2.42%	1.26%	-13.39%
2267	68 Neutral	¥762.80B	17.66	7.18%	2.67%	-3.87%	-16.49%
2501	63 Neutral	¥694.96B	35.48	3.63%	0.67%	0.25%	-58.68%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
2502	60 Neutral	¥2.57T	14.71	6.47%	3.23%	0.86%	0.55%
2579	60 Neutral	¥689.72B	-14.27	-12.00%	1.77%	2.07%	-751.72%